Industry & academia combine to support synthesis of squaric acid monoamides as building blocks for drug discovery Post author: Post published:November 5, 2023 Post category:uncategorized Asynt have collaborated with Kingston University and Key Organics to develop an accessible new synthetic compound library. You Might Also Like Optimum protection against diabetes: Weight loss plus remission of prediabetes June 30, 2024 Enfortumab vedotin and pembrolizumab show major benefits for urothelial carcinoma patients April 6, 2025 New research reveals persistent racial gap in stroke survival rates July 15, 2024
Enfortumab vedotin and pembrolizumab show major benefits for urothelial carcinoma patients April 6, 2025